Compare CLDX & LFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | LFST |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 2008 | 2021 |
| Metric | CLDX | LFST |
|---|---|---|
| Price | $29.45 | $6.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $43.80 | $9.00 |
| AVG Volume (30 Days) | 798.4K | ★ 2.0M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,599,000.00 | ★ $1,367,570,000.00 |
| Revenue This Year | N/A | $15.75 |
| Revenue Next Year | $19.70 | $14.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.39 |
| 52 Week Low | $14.40 | $3.74 |
| 52 Week High | $29.83 | $8.30 |
| Indicator | CLDX | LFST |
|---|---|---|
| Relative Strength Index (RSI) | 67.48 | 61.94 |
| Support Level | $25.69 | $6.26 |
| Resistance Level | $27.03 | $6.64 |
| Average True Range (ATR) | 1.32 | 0.20 |
| MACD | 0.48 | -0.03 |
| Stochastic Oscillator | 93.11 | 66.63 |
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.